Browsing Tag
cardiac devices
2 posts
Can the BACKBEAT trial validate a new category of device-driven hypertension therapy?
What does the BACKBEAT trial mean for Medtronic plc and Orchestra BioMed Holdings, Inc.? Discover the future of device-driven hypertension therapy.
Will Johnson & Johnson MedTech’s new CORE-VA registry finally bridge the real-world evidence gap in ventricular arrhythmia care?
Johnson & Johnson MedTech launches the CORE-VA registry to improve ventricular arrhythmia care with real-world data. Find out what it means for the sector!